top of page
Search Results

357 items found for "Interferon regulatory factor 1"

  • Structural dynamics of Smoothened (SMO) in ciliary membrane and its interaction with membrane lipids

    In the absence of HH signaling, SMO is inhibited by Patched 1 (PTC1; a 12 pass transmembrane domain protein

  • 📰 GPCR Weekly News

    Below is your Classified GPCR News at a glance for December 12 to December 18th, 2022. Sosei Heptares' Partner Pfizer Progresses its Oral GLP-1 Receptor Agonist PF-07081532 into Phase 2 Clinical GEM2023 (14-17 March 2023). 8th and final ERNEST Meeting May 3-7, 2023 in Crete. June 10 - 11. June 11-16, 2023. 19th World Congress of Basic & Clinical Pharmacology 2023. July 2 - 7.

  • 📰 GPCR Weekly News, June 24 to 30, 2024

    These online courses will be held on Thursdays at 10 am EST. Save the dates: Course 1: Strategies for Successful Lead Optimization of Candidate Molecules Dates 31st, 2024 GPCR Event Highlight Join us for an in-person event with the Adhesion GPCR Consortium: the 11th Adhesion G Protein-Coupled Receptor B1 (ADGRB1/BAI1) Generated from an Alternative Promoter in Intron 17 Adhesion GPCR Workshop July 12 - 17, 2026 | 20th World Congress of Basic and Clinical Pharmacology 2026

  • 📰 GPCR Weekly News, January 23 to 29, 2023

    SLAS2023 International Conference and Exhibition (February 25 - March 1, 2023). 2nd ERNEST Training School (March 14-17, 2023). SLAS 2023 Building Biology in 3D Symposium. (May 14 - 19, 2023) 8th and final ERNEST Meeting in Crete. (May 3 - 7, 2023). (June 10 - 11, 2023). (June 11 - 16, 2023). 19th World Congress of Basic & Clinical Pharmacology 2023.

  • 📰 GPCR Weekly News, February 26 to March 3, 2024

    Next week, on March 15th, we are hosting a symposium on GPCR activation and signaling. - 15 | Biologics 2024 March 13 - 15 | 9th German Pharm-Tox Summit March 23 - 24, 2024 | Ligand Recognition Molecular Gating Seminar March 24 - 29, 2024 | Ligand Recognition and Molecular Gating Conference April 1 5 - 10, 2024 | AACR Annual Meeting May 13 - 17, 2024 | 20th Annual PEGS Boston Summit May 16 - 19, 2024 Adhesion GPCR Workshop July 12 - 17, 2026 | 20th World Congress of Basic and Clinical Pharmacology 2026

  • Odorant receptors – a bit of smell for drug discovery

    For example, OR4M1 was proposed to interfere with aberrant tau hyperphosphorylation (Zhao W. et. al 2013

  • Therapeutic validation of an orphan G protein‐coupled receptor

    In this study Marsango et al. address two key questions in GPR84 biology and pharmacology: 1. how GPR84 alkylpyrimidine‐4,6‐diol derivatives (Liu et al., 2016; Zhang et al., 2016) and embelin (2,5‐dihydroxy‐3‐undecyl‐1,4 IM (3,3′‐methylenebis‐1H‐indole) has been identified as a positive allosteric modulator of GPR84, a metabolite

  • 📰 GPCR Weekly News, February 27 to March 5, 2023

    (March 14-17, 2023). SLAS 2023 Building Biology in 3D Symposium. (May 14 - 19, 2023) 8th and final ERNEST Meeting in Crete. (May 3 - 7, 2023). (June 10 - 11, 2023). (June 11 - 16, 2023). 11th Adrenoceptor Symposium: Adrenoceptors and GPCR Signalling (June 30 - July 1, 2023) 19th World Congress of Basic & Clinical Pharmacology 2023.

  • Transmembrane domains of GPCR dimers – a novel hot spot for drug discovery

    both homodimers and heterodimers with other members of the class A GPCR family such as with bradykinin 1

  • GPCRs are not simple on-off switches: deep dive into GPCR-ligand interactions

    demonstration of spontaneous or "constitutive" receptor activity was reported for the β2-adrenergic receptor in 1984 (Cerione et al. 1984), where reconstitution of purified β2-adrenergic receptors from guinea pig lung constitutively activate Gi proteins in a membrane preparation without the need for an agonist (Costa and Herz 1989 Natural and synthetic ligands can be categorized into four distinct efficacy classes: 1) full agonists

  • 📰 GPCR Weekly News, February 20 to 26, 2023

    Insights into GPCR Function Structure-based design of novel melanin-concentrating hormone receptor-1 (March 14-17, 2023). SLAS 2023 Building Biology in 3D Symposium. (May 14 - 19, 2023) 8th and final ERNEST Meeting in Crete. (May 3 - 7, 2023). (June 10 - 11, 2023). (June 11 - 16, 2023). 19th World Congress of Basic & Clinical Pharmacology 2023.

  • 📰 GPCR Weekly News, January 29 to February 4, 2024

    GPCR Members get 10% off with code MPDRGPCR10. Discovery March 13 - 15 | 9th German Pharm-Tox Summit March 23 - 24, 2024 | Ligand Recognition and Molecular Gating Seminar March 24 - 29, 2024 | Ligand Recognition and Molecular Gating Conference April 1 - 4, 10, 2024 | AACR Annual Meeting May 13 - 17, 2024 | 20th Annual PEGS Boston Summit May 16 - 19, 2024 Adhesion GPCR Workshop July 12 - 17, 2026 | 20th World Congress of Basic and Clinical Pharmacology 2026

  • Nanobodies: New Dimensions in GPCR Signaling Research

    -104710 Rasmussen, S. Nature, 469(7329), 175180. https://doi.org/10.1038/nature09648 Kruse, A. C., Ring, A. Nature, 504(7478), 101106. https://doi.org/10.1038/nature12735 Burg, J. S., Ingram, J. Science (New York, N.Y.), 347(6226), 11131117. https://doi.org/10.1126/science.aaa5026 Wu, A., Salom Nature communications, 14(1), 5209. https://doi.org/10.1038/s41467-023-40911-9

  • Targeting Intracellular Allosteric Sites in GPCRs

    modulators targeting GPCRs can display one or more of the following pharmacological characteristics: 1)

  • Unlocking the Therapeutic Potential of Previously Undruggable GPCRs

    As seen below in Figure 1, natural ligands do not make use of all the potential binding contacts with Figure 1. Proceedings of the National Academy of Sciences, 105(46), 1770617711. https://doi.org/10.1073/pnas.0805098105 Journal of Infectious Diseases, 199, 1525-1527. https://doi.org/10.1086/598685 · Demonstration , 1-10. https://doi.org/10.1016/j.pep.2015.10.011 · Demonstration of the feasibility of manufacturing

  • 📰 GPCR Weekly News, March 27 to April 4, 2023

    GPCR Symposium on GPCR Activation and Signaling held on May 19th, 2023. (May 14 - 19, 2023) 8th and final ERNEST Meeting in Crete. (May 3 - 7, 2023). (June 10 - 11, 2023). (June 11 - 16, 2023). 1, 2023) 19th World Congress of Basic & Clinical Pharmacology 2023.

  • Harnessing Deep Mutational Scanning for Enhanced Drug Discovery

    Trends in Biotechnology , 29 (9), 435–442. https://doi.org/10.1016/j.tibtech.2011.04.003 Fowler, D. Nature Protocols , 9 (9), 2267–2284. https://doi.org/10.1038/nprot.2014.153 Howard, M. BioRxiv (Cold Spring Harbor Laboratory) . https://doi.org/10.1101/2024.04.17.590000 Pines, G., Fankhauser Molecules , 25 (9), 2265. https://doi.org/10.3390/molecules25092265

  • Profiling Immune Cell and Platelet Transcriptomes

    The study reports that human white blood cells express an average of 160 GPCR mRNAs, ranging from 123 comparative analysis with previous studies, notably the work by Groot-Kormelink et al., which reported 165 The current study found that 133 of these receptors were also detected, highlighting the robustness of For further details, refer to the full article: DOI: 10.1038/s41597-024-03880-2

  • Targeted Drug Design through GPCR Mutagenesis: Insights from β2AR

    Interestingly, only 10 out of 82 important residues are within the ligand-binding pocket, resulting in

  • APEX2/AUR Biosensor: A Powerful Tool for Protein Interaction and Trafficking

    For further details, refer to the full article: DOI: 10.1038/s41589-024-01705-2

  • Exploring the Breakthroughs in GPCR Research

    📰 GPCR Weekly News, July 8 to 14, 2024 Hello readers! Check out our GPCR coverage for this week. We have 15 GPCR papers, three industry news, and two job ads.   Course Schedule and Details Every Thursday at 10 am EST Principles of Pharmacology in Drug Discovery Logo Contest : Unleash your creativity and submit your design by August 15, 2024. Adhesion GPCR Workshop July 12 - 17, 2026 | 20th World Congress of Basic and Clinical Pharmacology 2026

  • Do You Believe AI Could Accelerate Drug Discovery?

    For the σ2 receptor, AF2 predicted side-chain conformations with an RMSD of 1.1 Å from the crystal structure Of 161 molecules tested, 42 substituted more than 50% of [³H]-LSD at 10 μM, achieving a 26% hit rate. The highest affinity compounds (15 to 24 nM) were identified from AF2 docking. Science https://doi.org/10.1126/science.adn6354 (2024) Abramson, J., Adler, J., Dunger, J. et al. Nature 630, 493–500 (2024). https://doi.org/10.1038/s41586-024-07487-w

  • 📰 GPCR Weekly News, April 29 to May 5, 2024

    Today, we celebrate a huge milestone by releasing Episode #150 of the Dr. GPCR Podcast.

  • Chemokine receptor-targeted drug discovery: progress and challenges

    different patterns of receptor recycling where CCR5 recycles back to the cell surface (Mack et al. 1998 restored to the cell surface and partially targeted to lysosomes (Zimmermann, Conkright, and Rothenberg 1999 only interact with the extracellular domain of the receptor ((Zimmermann, Conkright, and Rothenberg 1999

  • VAMP2: a crucial player in the delivery of MOR to the synapse

    interact with other GPCRs, such as the beta-2 adrenergic receptor and the mu-opioid receptor (MOR) [1,6,7 Elife. 10:e67478. Drake, M.T., S.K. Shenoy, and R.J. Lefkowitz. 2006. Science. 294:11171122. 5. Endocrinol. 22:18811892. Wickner, W., and R. Schekman. 2008. Membrane fusion. Nat. Struct. Mol. Biol. 15:658–664.

  • 📰 GPCR Weekly News - January 2 to 8, 2023

    Deadline February 12, 2023 Current Technologies To Understand G-Protein-Coupled Receptor Molecular Pharmacology GEM2023 (14-17 March 2023). 8th and final ERNEST Meeting May 3-7, 2023 in Crete. June 10 - 11. June 11-16, 2023. 19th World Congress of Basic & Clinical Pharmacology 2023. July 2 - 7.

  • TM5-TM6: structural switches that modulate the coupling of serotonin receptors to Gs or Gi

    TM5 and TM6 regions of 27 class A GPCRs coupled to Gs or Gi/o yielded similar results, TM5 was 5.6 ± 1.5 residues longer while TM6 was 2.6 ± 1.6 residues shorter, concluding that the TM5-TM6 macro-switch length

  • Molecular basis for variations in the sensitivity of pathogenic rhodopsin variants to 9-cis-retinal

    September 2022 "Over 100 mutations in the rhodopsin gene have been linked to a spectrum of retinopathies work, we utilize deep mutational scanning to quantitatively compare the plasma membrane expression of 123

bottom of page